Login / Register The Most Trusted Name in Medical Education

Pathology

Elsevier's complimentary continuing medical education courses in pathology are targeted to healthcare providers in lab medicine.

Thumbnail 116x140 LearningCenter v2

Progress in Pancreatic Cancer

Format: Resource Center

Welcome to the Progress in Pancreatic Cancer Learning Center. This Learning Center is a freely accessible, educational platform for healthcare providers who treat patients with pancreatic cancer

Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information for the treatment of patients with pancreatic cancer. Within this learning center, you will have access to complimentary continuing medical education (CME) activities highlighting up-to-the-minute emerging evidence that can be applied to everyday practice. Additional resources include open access to the full text of relevant peer-reviewed articles, clinical guidelines, interactive infographics, and other materials dedicated to helping you improve patient care.

As new data emerge, we will be updating the Progress in Pancreatic Cancer Learning Center with new CME activities and timely materials, so please check back often for the latest offerings.

We know you will find these resources helpful in your clinical practice, and hope that you will make the Progress in Pancreatic Cancer Learning Center your destination for pancreatic cancer education.

Take Course »

Credits: 0.75 AMA PRA Category 1 Credit™ per module
1 BANNER

Management of Patients with Relapsed/Refractory Multiple Myeloma: Elsevier CME Independent Conference Highlights from EBMT and EHA 2018

Format: Conference Reporter

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

In this CME-accredited webcast, three experts discuss the clinical implications of some of the latest important research on relapsed/refractory multiple myeloma (RRMM). The roundtable discussion covers new data presented at the 2018 annual meetings of the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT). The topics discussed include: unmet needs in the treatment of RRMM; new data on treatment strategies (including the roles of proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies); and emerging treatments, such as chimeric antigen receptor (CAR) T-cell therapies. 

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
Elsevier SITC ASCO 2018 01 Web 116x140 webcast

The IO Quiz Show: Biomarkers for Immunotherapy

Format: Webcast

This webcast was recorded at a live event at ASCO SITC 2018. During this event, three leading experts challenged participants with quiz questions, which formed a basis for in-depth discussions supported by slide presentations. Participants were able to test and expand their knowledge on the increasingly important role of biomarkers in immuno-oncology. The experts examined the tumor microenvironment and addressed the evidence base for, and the future potential of, current and emerging biomarkers in guiding treatment decisions and in predicting the response to immuno-oncology therapeutics. Participants also learned about the role and importance of next-generation sequencing for the evaluation of novel immune biomarkers and for daily clinical practice.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credits™
Bladder Cancer banner 116x140

Management of Patients with Bladder Cancer, Elsevier CME Independent Conference Highlights of the ASCO-GU Genitourinary Cancer Symposiums 2018*

Format: Webcast

This conference reporter webcast on bladder cancer is based on a roundtable discussion by three experts. During the webcast they provide an overview of challenges in the management of bladder cancer and summarize and discuss recent data presented during the ASCO-GU 2018 Symposium. The experts examine clinical trial outcomes of immunotherapies for bladder cancer and address the question of how current, novel, and emerging treatment options (when approved) could be implemented in individualized treatment plans to optimize treatment selection and outcomes for patients with bladder cancer.

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
Colorectal Cancer banner 116x140

Management of Patients with Colorectal Cancer, Elsevier CME Independent Conference Highlights of the ASCO-GI 2018 Annual Meeting*

Format: Webcast

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

This conference reporter webcast on colorectal cancer is based on a roundtable discussion by three experts. During the webcast they provide an overview of challenges in the management of colorectal cancer and summarize and discuss recent data presented during the ASCO-GI 2018 Symposium. The experts examine clinical trial outcomes of targeted therapies for colorectal cancer and address the question of how current, novel, and emerging treatment options (when approved) could be implemented in individualized treatment plans to optimize treatment selection and outcomes for patients with colorectal cancer.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
ASH 2017 IMMUNO banner 116x140 thumbnail

Immunotherapy in Hematological Malignancies

Format: Webcast

This is a CME-accredited Elsevier Conference Reporter webcast based on a virtual roundtable discussion on immunotherapy in hematological malignancies. During the discussion three key opinion leaders summarize and give their expert opinion on important data from abstracts presented at the American Society of Hematology (ASH) 2017 Annual Meeting. The webcast lasts approximately 1 hour.

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference coverage educational programs.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™
ASH 2017 Update MM banner 116x140

Management of Patients With Relapsed and/or Refractory Multiple Myeloma

Format: Webcast

This is a CME-accredited Elsevier Conference Reporter webcast based on a virtual roundtable discussion on the management of patients with relapsed and/or refractory multiple myeloma. During the virtual roundtable discussion, 3 experts summarize and give their expert opinion on important data from abstracts presented at the American Society of Hematology Association (ASH) 2017 Annual Meeting.

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™